Evolution-guided discovery of antibiotics that inhibit peptidoglycan remodelling
AbstractAddressing the ongoing antibiotic crisis requires the discovery of compounds with novel mechanisms of action that are capable of treating drug-resistant infections1. Many antibiotics are sourced from specialized metabolites produced by bacteria, particularly those of the Actinomycetes family2. Although actinomycete extracts have traditionally been screened using activity-based platforms, this approach…
bubmagFebruary 12, 2020